Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 24

Sort by

Sort Order Select

Journal Articles

The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes

Peng Hua, Joanna Hester, George Adigbli, Rong Li, Bethan Psaila, Anindita Roy, Carole J. R. Bataille, Graham M. Wynne, Thomas Jackson, Thomas A. Milne, Angela J. Russell, James Davies, Irene Roberts, Fadi Issa, Suzanne M. Watt

Blood (2020) 136 (21): 2410–2415.

https://doi.org/10.1182/blood.2020005357

Published: 2020

Includes: Supplemental data

Journal Articles

Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone

D Puthier, R Bataille, S Barille, MP Mellerin, JL Harousseau, A Ponzio, N Robillard, J Wijdenes, M Amiot

Blood (1996) 88 (12): 4659–4666.

https://doi.org/10.1182/blood.V88.12.4659.bloodjournal88124659

Published: 1996

Journal Articles

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop

ZJ Gu, V Costes, ZY Lu, XG Zhang, V Pitard, JF Moreau, R Bataille, J Wijdenes, JF Rossi, B Klein

Blood (1996) 88 (10): 3972–3986.

https://doi.org/10.1182/blood.V88.10.3972.bloodjournal88103972

Published: 1996

Journal Articles

Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies

R Bataille, D Chappard, MF Basle

Blood (1996) 87 (11): 4762–4769.

https://doi.org/10.1182/blood.V87.11.4762.bloodjournal87114762

Published: 1996

Journal Articles

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement [letter]

P Moreau, N Milpied, P de Faucal, T Petit, P Herbouiller, R Bataille, JL Harousseau

Blood (1996) 87 (7): 3063–3064.

https://doi.org/10.1182/blood.V87.7.3063.bloodjournal8773063

Published: 1996

Journal Articles

Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after [letter]

C Pellat-Deceunynk, M Amiot, R Bataille, I Van Riet, B Van Camp, P Omede, M Boccadoro

Blood (1995) 86 (10): 4001–4002.

https://doi.org/10.1182/blood.V86.10.4001.bloodjournal86104001

Published: 1995

Journal Articles

Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin

S Barille, M Collette, R Bataille, M Amiot

Blood (1995) 86 (8): 3151–3159.

https://doi.org/10.1182/blood.V86.8.3151.3151

Published: 1995

Journal Articles

Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments

ZY Lu, H Brailly, J Wijdenes, R Bataille, JF Rossi, B Klein

Blood (1995) 86 (8): 3123–3131.

https://doi.org/10.1182/blood.V86.8.3123.3123

Published: 1995

Journal Articles

Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11

M Cherel, M Sorel, B Lebeau, S Dubois, JF Moreau, R Bataille, S Minvielle, Y Jacques

Blood (1995) 86 (7): 2534–2540.

https://doi.org/10.1182/blood.V86.7.2534.2534

Published: 1995

Journal Articles

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma

R Bataille, B Barlogie, ZY Lu, JF Rossi, T Lavabre-Bertrand, T Beck, J Wijdenes, J Brochier, B Klein

Blood (1995) 86 (2): 685–691.

https://doi.org/10.1182/blood.V86.2.685.bloodjournal862685

Published: 1995

Journal Articles

Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells

ZY Lu, XG Zhang, C Rodriguez, J Wijdenes, ZJ Gu, B Morel-Fournier, JL Harousseau, R Bataille, JF Rossi, B Klein

Blood (1995) 85 (9): 2521–2527.

https://doi.org/10.1182/blood.V85.9.2521.bloodjournal8592521

Published: 1995

Journal Articles

Interleukin-6 in human multiple myeloma

B Klein, XG Zhang, ZY Lu, R Bataille

Blood (1995) 85 (4): 863–872.

https://doi.org/10.1182/blood.V85.4.863.bloodjournal854863

Published: 1995

Journal Articles

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells

C Pellat-Deceunynck, R Bataille, N Robillard, JL Harousseau, MJ Rapp, N Juge- Morineau, J Wijdenes, M Amiot

Blood (1994) 84 (8): 2597–2603.

https://doi.org/10.1182/blood.V84.8.2597.2597

Published: 1994

Journal Articles

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma

XG Zhang, JP Gaillard, N Robillard, ZY Lu, ZJ Gu, M Jourdan, JM Boiron, R Bataille, B Klein

Blood (1994) 83 (12): 3654–3663.

https://doi.org/10.1182/blood.V83.12.3654.3654

Published: 1994

Journal Articles

Plasma cell labeling index, beta 2-microglobulin, and C-reactive protein: what is the best combination for myeloma prognosis? [letter; comment]

M Boccadoro, G Gallone, R Frieri, A Pileri, R Bataille, B Klein

Blood (1993) 82 (11): 3507–3508.

https://doi.org/10.1182/blood.V82.11.3507.3507

Published: 1993

Journal Articles

gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro

M Portier, XG Zhang, E Caron, ZY Lu, R Bataille, B Klein

Blood (1993) 81 (11): 3076–3082.

https://doi.org/10.1182/blood.V81.11.3076.3076

Published: 1993

Journal Articles

Serum levels of beta 2 microglobulin and interleukin-6 to differentiate monoclonal gammopathy of undetermined significance [letter; comment]

R Bataille, B Klein

Blood (1992) 80 (9): 2433–2434.

https://doi.org/10.1182/blood.V80.9.2433.2433

Published: 1992

Journal Articles

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system

R Bataille, M Boccadoro, B Klein, B Durie, A Pileri

Blood (1992) 80 (3): 733–737.

https://doi.org/10.1182/blood.V80.3.733.733

Published: 1992

Journal Articles

Serum beta-2-microglobulin (beta 2m) in myeloma: toward a simple prognostic stratification using beta 2M and acute-phase proteins? [letter; comment]

R Bataille, B Klein

Blood (1991) 77 (7): 1616–1617.

https://doi.org/10.1182/blood.V77.7.1616.1616

Published: 1991

Journal Articles

Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells [see comments]

XG Zhang, R Bataille, M Jourdan, S Saeland, J Banchereau, P Mannoni, B Klein

Blood (1990) 76 (12): 2599–2605.

https://doi.org/10.1182/blood.V76.12.2599.2599

Published: 1990

NARROW

The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes

Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop

Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement [letter]

Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after [letter]

Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin

Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments

Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma

Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells

Interleukin-6 in human multiple myeloma

Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma

Plasma cell labeling index, beta 2-microglobulin, and C-reactive protein: what is the best combination for myeloma prognosis? [letter; comment]

gamma-Interferon in multiple myeloma: inhibition of interleukin-6 (IL- 6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro

Serum levels of beta 2 microglobulin and interleukin-6 to differentiate monoclonal gammopathy of undetermined significance [letter; comment]

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system

Serum beta-2-microglobulin (beta 2m) in myeloma: toward a simple prognostic stratification using beta 2M and acute-phase proteins? [letter; comment]

Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells [see comments]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only